About Anuj Singhal
Form D filings for KALM Therapeutics in 2024 list Anuj Singhal as executive officer and director.
Anuj Singhal first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Anuj Singhal in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Anuj Singhal works with at each company, as listed on that company's latest Form D.
KALM Therapeutics, Inc. · Form D, Aug 9, 2024
CS
Chris Seibert
President and director